» Articles » PMID: 2004345

Candida Mannan: Chemistry, Suppression of Cell-mediated Immunity, and Possible Mechanisms of Action

Overview
Specialty Microbiology
Date 1991 Jan 1
PMID 2004345
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

The ability of Candida albicans to establish an infection involves multiple components of this fungal pathogen, but its ability to persist in host tissue may involve primarily the immunosuppressive property of a major cell wall glycoprotein, mannan. Mannan and oligosaccharide fragments of mannan are potent inhibitors of cell-mediated immunity and appear to reproduce the immune deficit of patients with the mucocutaneous form of candidiasis. However, neither the exact structures of these inhibitory species nor their mechanisms of action have yet been clearly defined. Different investigators have proposed that mannan or mannan catabolites act upon monocytes or suppressor T lymphocytes, but research from unrelated areas has provided still other possibilities for consideration. These include interference with cytokine activities, lymphocyte-monocyte interactions, and leukocyte homing. To stimulate further research of the immunosuppressive property of C. albicans mannan, we have reviewed (i) the relationship of mannan to other antigens and virulence factors of the fungus; (ii) the chemistry of mannan, together with methods for preparation of mannan and mannan fragments; and (iii) the historical evidence for immunosuppression by Candida mannan and the mechanisms currently proposed for this property; and (iv) we have speculated upon still other mechanisms by which mannan might influence host defense functions. It is possible that understanding the immunosuppressive effects of mannan will provide clues to novel therapies for candidiasis that will enhance the efficacy of both available and future anti-Candida agents.

Citing Articles

Metabolomics Provides New Insights into Host Manipulation Strategies by (Hymenoptera: Braconidae), a Fruit Fly Parasitoid.

Liu S, Zhang J, Sheng Y, Feng T, Shi W, Lu Y Metabolites. 2023; 13(3).

PMID: 36984776 PMC: 10053316. DOI: 10.3390/metabo13030336.


Conidium Specific Polysaccharides in .

Liu Z, Valsecchi I, Le Meur R, Simenel C, Guijarro J, Comte C J Fungi (Basel). 2023; 9(2).

PMID: 36836270 PMC: 9964227. DOI: 10.3390/jof9020155.


Candida albicans PPG1, a serine/threonine phosphatase, plays a vital role in central carbon metabolisms under filament-inducing conditions: A multi-omics approach.

A L Bataineh M, Soares N, Semreen M, Cacciatore S, Dash N, Hamad M PLoS One. 2021; 16(12):e0259588.

PMID: 34874940 PMC: 8651141. DOI: 10.1371/journal.pone.0259588.


and Oral Carcinogenesis. A Brief Review.

Di Cosola M, Cazzolla A, Charitos I, Ballini A, Inchingolo F, Santacroce L J Fungi (Basel). 2021; 7(6).

PMID: 34204731 PMC: 8231483. DOI: 10.3390/jof7060476.


Carbohydrate Conjugates in Vaccine Developments.

Lang S, Huang X Front Chem. 2020; 8:284.

PMID: 32351942 PMC: 7174737. DOI: 10.3389/fchem.2020.00284.


References
1.
Cutler J, Friedman L, MILNER K . Biological and chemical characterization of toxic substances from Candida albicans. Infect Immun. 1972; 6(4):616-27. PMC: 422583. DOI: 10.1128/iai.6.4.616-627.1972. View

2.
Muchmore A, Decker J, Blaese R . Evidence that specific oligosaccharides block early events necessary for the expression of antigen-specific proliferation by human lymphocytes. J Immunol. 1980; 125(3):1306-11. View

3.
Gatenby P, Basten A, Adams E . Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function. J Clin Lab Immunol. 1980; 3(3):209-16. View

4.
Piccolella E, Lombardi G, Morelli R . Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response. J Immunol. 1980; 125(5):2082-8. View

5.
Manning M, Mitchell T . Analysis of cytoplasmic antigens of the yeast and mycelial phases of Candida albicans by two-dimensional electrophoresis. Infect Immun. 1980; 30(2):484-95. PMC: 551338. DOI: 10.1128/iai.30.2.484-495.1980. View